Hims & Hers Expands Its Leadership Bench — Adding Two SVPs To Oversee Human Resources and Men’s Sexual Health/Urology, Respectively
Tags: Telehealth, Leadership, Hiring, Healthcare, Wellness

Hims & Hers Expands Its Leadership Bench — Adding Two SVPs To Oversee Human Resources and Men’s Sexual Health/Urology, Respectively Hims Follow Dec 14, 2020 · 8 min read

Welcoming Jeremious Henderson and Dr. Peter Stahl to The Team

Hims & Hers has entered a critical stage for its business as the company pursues a previously announced proposed business combination with Oaktree Acquisition Corp. To ensure Hims & Hers continues to grow the strategic power to execute on the company’s mission of providing high-quality care for an increasingly broad range of patient needs, the team has hired two experts in their respective fields to join the team. Jeremious Henderson joins the company as Senior Vice President of Human Resources, while Dr. Peter Stahl will serve as the Senior Vice President of Men’s Sexual Health and Urology.

“We are pioneering a new way for patients to access healthcare,” said Hims & Hers Co-Founder and CEO Andrew Dudum. “As a quickly growing organization, we’re focused on hiring leaders with the knowledge and ability to push our business to the next level, and help us expand access to affordable, convenient, high-quality care for people across the country. I couldn’t be more thrilled to have Jeremious on the team to lead HR. His extensive experience as a leading-edge HR leader will undoubtedly move the needle in helping our employees, and expanding company, flourish. Beyond that, I’m thrilled to officially welcome Dr. Stahl to our team, having worked with us in an advisor capacity since before launching Hims three years ago. Dr. Stahl is a board-certified urologist and an extremely talented medical professional whose expertise building and leading clinical and research programs has been critical to Hims’ success. Leveraging many years of medical and telemedicine experience related to men’s sexual health, I am confident Dr. Stahl will help us continue to develop the premier virtual care experience for men.”

Jeremious Henderson — SVP of Human Resources

Jeremious Henderson is an innovative people and culture leader, serving in an executive capacity for more than 15 years. In his role as Hims & Hers’ first-ever SVP of HR, Jeremious will influence and drive transformative decision-making in all functions of HR including diversity, inclusion and equity (DE&I), compensation, benefits, recruiting, performance management, and more. In addition, this is a particularly important time for the company as it is now remote-first, and part of his role will be helping to navigate this new way of work.

Previously, Jeremious worked at FINRA for 13 years, his most recent position at the company as VP of Rewards and Intelligence. Prior to that role, he was the Senior Director of Diversity & WorkLife. Jeremious has also held various human resources positions at Capital One, IBM and Hewlett-Packard. He attended Morehouse College for undergrad and the Krannert Graduate School of Management at Purdue where he received a MS in HR. Recently, Jeremious received a HR Analytics Certification from Cornell University.

Dr. Peter Stahl — SVP of Men’s Sexual Health and Urology

Dr. Stahl is a board-certified urologist and nationally recognized leader in male reproductive and sexual medicine. He is a member of multiple national and international urology organizations and author of more than 50 journal articles and textbook chapters about men’s urological health. Dr. Stahl most recently served as Associate Professor of Urology at the Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, where he built and led clinical and research programs in male reproductive & sexual medicine from 2012 until today.

Dr. Stahl has served as a Clinical Advisor on Hims’ Medical Advisory Board since the company’s fruition. In his expanded role at Hims & Hers as SVP of Men’s Sexual Health and Urology, he will focus on growing and continuously improving the company’s male sexual health and urology offerings. He will leverage his clinical experience, insight and relationships to ensure that Hims & Hers continues to lead the way in the rapidly expanding men’s telehealth space.

To learn more about Hims & Hers business, you can visit forhims.com/investors.

Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements. Forward-looking statements generally relate to future events or Hims & Hers’ future financial or operating performance. For example, statements about the completion of the proposed business combination, the benefits of the proposed business combination, the competitive environment, and the expected future performance, growth and market opportunities of Hims & Hers are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Oaktree Acquisition Corp. and its management, and Hims & Hers and its management, as the case may be, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements with respect to the proposed business combination between Hims & Hers and Oaktree Acquisition Corp.; (2) the outcome of any legal proceedings that may be instituted against Oaktree Acquisition Corp., Hims & Hers, the combined company or others following the announcement of the proposed business combination; (3) the inability to complete the proposed business combination due to the failure to obtain approval of the shareholders of Oaktree Acquisition Corp. or to satisfy other conditions to closing, including the satisfaction of the minimum trust account amount following any redemptions; (4) changes to the proposed structure of the business combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the proposed business combination; (5) the ability to meet stock exchange listing standards at or following the consummation of the proposed business combination; (6) the risk that the proposed business combination disrupts current plans and operations of Hims & Hers as a result of the announcement and consummation of the proposed business combination; (7) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the proposed business combination; (9) changes in applicable laws or regulations; (10) the possibility that Hims & Hers or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the limited operating history of Hims & Hers; (12) the Hims & Hers business is subject to significant governmental regulation; (13) the Hims & Hers business may not successfully expand into other markets, including womens’ health; and (14) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Oaktree Acquisition Corp.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and which is set forth in the registration statement on Form S-4 filed by Oaktree Acquisition Corp. with the SEC in connection with the proposed business combination. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Neither Oaktree Acquisition Corp. nor Hims & Hers undertakes any duty to update these forward-looking statements.

Additional Information and Where to Find It

Oaktree Acquisition Corp. has filed a Registration Statement on Form S-4 containing a proxy statement/prospectus relating to the proposed business combination with the SEC, which will be mailed to its shareholders once definitive. This communication does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in respect of the proposed business combination. Oaktree Acquisition Corp.’s shareholders and other interested persons are advised to read the preliminary proxy statement/prospectus and, when available, the amendments thereto and the definitive proxy statement/prospectus and other documents filed in connection with the proposed business combination, as these materials will contain important information about Oaktree Acquisition Corp., Hims & Hers and the proposed business combination. When available, the definitive proxy statement/prospectus and other relevant materials for the proposed business combination will be mailed to shareholders of Oaktree Acquisition Corp. as of a record date to be established for voting on the proposed business combination. Shareholders of Oaktree Acquisition Corp. will also be able to obtain copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus and other documents filed with the SEC, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a written request to: Oaktree Acquisition Corp., 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071.

Participants in the Solicitation

Oaktree Acquisition Corp. and its directors and executive officers may be deemed participants in the solicitation of proxies from Oaktree Acquisition Corp.’s shareholders with respect to the proposed business combination. A list of the names of those directors and executive officers and a description of their interests in Oaktree Acquisition Corp. is contained in Oaktree Acquisition Corp.’s annual report on Form 10-K for the fiscal year ended December 31, 2019, which was filed with the SEC, and in the proxy statement/prospectus for the proposed business combination, which are available free of charge at the SEC’s web site at www.sec.gov, or by directing a request to Oaktree Acquisition Corp., 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071.

Hims & Hers and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Oaktree Acquisition Corp. in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination is included in the proxy statement/prospectus for the proposed business combination.

Non-Solicitation

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential business combination and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Oaktree Acquisition Corp., the Company or the combined company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.